Explore >> Select a destination
|
You are here 
|
f1000research.com | ||
| | | | |
www.nature.com
|
|
| | | | | Timely evaluation of the protective effects of Coronavirus Disease 2019 (COVID-19) vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern is urgently needed to inform pandemic control planning. Based on 78 vaccine efficacy or effectiveness (VE) data from 49 studies and 1,984,241 SARS-CoV-2 sequences collected from 31 regions, we analyzed the relationship between genetic distance (GD) of circulating viruses against the vaccine strain and VE against symptomatic in... | |
| | | | |
fharrell.com
|
|
| | | | | This article provides my reflections after the PCORI/PACE Evidence and the Individual Patient meeting on 2018-05-31. The discussion includes a high-level view of heterogeneity of treatment effect in optimizing treatment for individual patients. | |
| | | | |
errorstatistics.com
|
|
| | | | | Stephen Senn Head of Competence Center for Methodology and Statistics (CCMS) Luxembourg Institute of Health Twitter @stephensenn Being a statistician means never having to say you are certain A recent discussion of randomised controlled trials[1] by Angus Deaton and Nancy Cartwright (D&C) contains much interesting analysis but also, in my opinion, does not escape rehashing... | |
| | | | |
www.fharrell.com
|
|
| | | This is the story of what influenced me to become a Bayesian statistician after being trained as a classical frequentist statistician, and practicing only that mode of statistics for many years. | ||
